+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

From
From
From
Biosimilars World Market - Product Thumbnail Image

Biosimilars World Market

  • Report
  • January 2023
  • 28 Pages
  • Global
From
From
From
The Biosimilars Landscape in Japan: 2009-2020 Study - Product Thumbnail Image

The Biosimilars Landscape in Japan: 2009-2020 Study

  • Report
  • January 2020
  • 156 Pages
  • Japan
From
From
AbbVie Hit Harder By EU Humira Biosimilars Than Projected - Product Thumbnail Image

AbbVie Hit Harder By EU Humira Biosimilars Than Projected

  • Newsletter
  • November 2024
  • 3 Pages
  • Europe
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more